Systemic thromboembolism in children

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 722-728

  Kuhle, Stefan ^a,b   Massicotte, Patricia ^a   Chan, Anthony ^c   Adams, Margaret ^a   Abdolell, Mohamed ^d,e   de Veber, Gabrielle ^a   Mitchell, Lesley ^a,e,f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

^d Ontario Government   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Children; Diagnosis; Epidemiology; Thromboembolism; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; AGE; ARTERY SURGERY; ARTERY THROMBOSIS; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILD CARE; CHILD HEALTH CARE; CONSULTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT INFORMATION; PATIENT REFERRAL; PHLEBOGRAPHY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; TELEPHONE; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ARTERIAL OCCLUSIVE DISEASES; CATHETERIZATION; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; REFERRAL AND CONSULTATION; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 6344289478     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-04-0207     Document Type: Article

References (21)

1. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-7.
2. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96: 939-43.
3. Kuhle S, Koloshuk B, Marzinotto V, et al. A cross-sectional study evaluating post thrombotic syndrome in children. Throm Res 2003; 11: 227-33.
4. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763-6.
5. Hausler M, Hubner D, Delhaas T, et al. Long term complications of inferior vena cava thrombosis. Arch Dis Child 2001; 85: 228-33.
6. Gurgey A, Aslan D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 2001; 23: 159-64.
7. van Ommen CH, Ottenkamp J, Lam J, et al. The risk of postthrombotic syndrome in children with congenital heart disease. J Pediatr 2002; 141: 582-6.
8. Nowak-Gottl U, Von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163-F167
9. van Ommen CH, Heijboer H, Buller HR, et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001; 139: 676-81.
10. Andrew M. Society for Pediatric Research Presidential Address: The 1-800-NO-CLOTS: A common vision. Pediatr Res 1998; 44: 964-73.
11. Heit JA, O'Fallon WM, Petterson TM et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population based study. Arch Int Med 2002; 162: 1245-8.
12. Mitchell L, Andrew M, Hanna K, et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Cancer 2003; 97: 508-16.
13. Prandoni P, Bernardi E. Upper extremity deep vein thrombosis. Curr Opin Pulm Med 1999; 5: 222-6.
14. Male C, Chait P, Ginsberg J, et al. Comparison of venography and ultrasound for the diagnosis of deep vein thrombosis in the upper body in children: A substudy of the PARKAA trial. Thromb Haemost 2002; 87: 593-98.
15. Roy M, Turner-Gomes S, Gill G et al. Accuracy of doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. J Pediatr 2002; 140: 131-4.
16. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
17. Mitchell L, Piovella F, Ofosu F, et al. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 1991; 78: 2299-304.
18. Monagle P, Chan AK, Albisetti M, et al. The fibrinolytic system in adolescents: Response to venous occlusion stress tests. Pediatr Res 2003; 53: 333-7.
19. Revel-Vilk S, Chan AK, Bauman M, et al. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic events. J Throm Haemost 2003; 1: 915-21.
20. Monagle P, Michelson AD, Bovill E, et al. Antithrombotic therapy in children. Chest 2001; 119: 344S-70S.
21. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-14.